Virginia G Kaklamani (Virginia Kaklamani)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

Cancer

University of Texas Health Science Center at San Antonio

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Health Science Center at San Antonio Nov 01 2014

United States

Professor :: Medicine

Publications

Kelly E McCann, Shari B Goldfarb, Tiffany A Traina, Meredith M Regan, Neelima Vidula, Virginia G Kaklamani
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ breast cancer 10 (1) (2024)
Aditya Bardia, Javier Cortes, Francois-Clement Bidard, Patrick Neven, José Angel García-Saenz, Philippe Aftimos, Joyce O'Shaughnessy, Janice Lu, Giulia Tonini, Simona Scartoni, Alessandro Paoli, Monica Binaschi, Tomer Wasserman, Virginia G Kaklamani
Elacestrant in ER+, HER2- MBC with ESR1-mutated tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy Plus CDK4/6 Inhibitor and in Clinical Subgroups. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Kelly E McCann, Shari B Goldfarb, Tiffany A Traina, Meredith M Regan, Neelima Vidula, Virginia G Kaklamani
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ breast cancer 10 (1) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kelly E McCann, Shari B Goldfarb, Tiffany A Traina, Meredith M Regan, Neelima Vidula, Virginia G Kaklamani
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer. NPJ breast cancer 10 (1) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Jingtong Zhai, Yun Wu, Zongbi Yi, Virginia G Kaklamani, Bing-He Xu
Advances in medical treatment of breast cancer in 2022. Cancer innovation 2 (1) (2023)
Yash B Shah, Stephanie Kjelstrom, Diana Martinez, Adam Leitenberger, Donna-Marie Manasseh, Melissa Bollmann-Jenkins, Ann Partridge, Virginia G Kaklamani, Rowan T Chlebowski, Sharon Larson, Marisa C Weiss
Risk factors for heightened COVID-19-Related anxiety among breast cancer patients. Cancer medicine (2022)
Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, Guillermo Streich, Alberto J Montero, Frédéric Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn, Donatienne Taylor, Kathleen K Harnden, Hung T Khong, Judit Kocsis, Florence Dalenc, Patrick M Dillon, Sunil Babu, Simon H Waters, Ines Deleu, José A García Sáenz, Emilio Bria, Marina Elena Cazzaniga, Janice Lu, Philippe Aftimos, Javier Cortes, Shubin Liu, Giulia Tonini, Dirk Laurent, Nassir Habboubi, Maureen G Conlan, Aditya Bardia
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Marisa C Weiss, Julianne E Hibbs, Meghan E Buckley, Sherry R Danese, Adam Leitenberger, Melissa Bollmann-Jenkins, Sam Meske, Katherine E Aliano-Ruiz, Theresa W McHugh, Sharon L Larson, Elaine H Le, Nancye L Green, Paul B Gilman, Virginia G Kaklamani, Rowan T Chlebowski, Diana M Martinez
Reply to the siren's song of anonymous web-based sampling. Cancer 128 (9) (2022)
Stephanie Soewito, Rachel B Wyatt Castillo, Emily Berenson, Natalie Poullard, Shawn Gessay, Lindsey Mette, Elena Marin, Kristin Shelby, Elise Alvarez, Byeong Yeob Choi, Clarissa Aviles, Anna Maria Pulido-Saldivar, Pamela M Otto, Ismail Jatoi, Chethan Ramamurthy, Myron Ignatius, Virginia G Kaklamani, Gail E Tomlinson
Disparities in Cancer Genetic Testing and Variants of Uncertain Significance in the Hispanic Population of South Texas. JCO oncology practice 18 (5) (2022)
Francois-Clement Bidard, Virginia G Kaklamani, Aditya Bardia
Reply to R. Nishihara et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Marisa C Weiss, Julianne E Hibbs, Meghan E Buckley, Sherry R Danese, Adam Leitenberger, Melissa Bollmann-Jenkins, Sam W Meske, Katherine E Aliano-Ruiz, Theresa W McHugh, Sharon L Larson, Elaine H Le, Nancye L Green, Paul B Gilman, Virginia G Kaklamani, Rowan T Chlebowski, Diana M Martinez
A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment. Cancer (2021)
Aditya Bardia, Virginia G Kaklamani, Sharon Wilks, Amy Weise, Donald Richards, Wael Harb, Cynthia Osborne, Robert Wesolowski, Meghan Karuturi, Paul Conkling, Rebecca G Bagley, Yamei Wang, Maureen G Conlan, Peter Kabos
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Sara M Tolaney, Kevin Kalinsky, Virginia G Kaklamani, David R D'Adamo, Gursel Aktan, Michaela L Tsai, Ruth M O'Regan, Peter A Kaufman, Sharon T Wilks, Eleni Andreopoulou, Debra A Patt, Yuan Yuan, Grace Wang, Claudio Savulsky, Dongyuan Xing, Ella Kleynerman, Vassiliki Karantza, Sami Diab
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Melinda L Telli, Charles Chu, Sunil S Badve, Shaveta Vinayak, Daniel P Silver, Steven J Isakoff, Virginia G Kaklamani, William Gradishar, Vered Stearns, Roisin M Connolly, James M Ford, Joshua J Gruber, Sylvia Adams, Judy E Garber, Nadine Tung, Chris Neff, Ryan Bernhisel, Kirsten M Timms, Andrea L Richardson
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2019)
Guang Chen, Xiao-Fei Ding, Kyle Pressley, Hakim Bouamar, Bing-Zhi Wang, Guixi Zheng, Larry E Broome, Alia Nazarullah, Andrew J Brenner, Virginia G Kaklamani, Ismail Jatoi, Lu-Zhe Sun
Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)

Virginia G Kaklamani.css-eqlu8i{font-size:small;padding-left:4px;} (Virginia Kaklamani)

Publication Activity (10 Years)

Top Topics

Top Venues

Virginia G Kaklamani (Virginia Kaklamani)